Dr. Gregory S. Hageman awarded Pisart Vision Award

Sunday, January 22, 2012 09:05 AM

Dr. Gregory S. Hageman, an accomplished researcher in the field of age-related macular degeneration (AMD), received Lighthouse International's Pisart Vision Award for his significant advances in AMD research.

Hageman's recent concept that AMD is multiple distinct diseases—if confirmed in future studies—is expected to change thinking related to the development of treatments, diagnostics and the design of clinical trials for a disease that afflicts more than 30 million people worldwide. In addition, his discoveries are expected to alter research practices and methods.

The Pisart Vision Award is given annually by Lighthouse International, a nonprofit, to an individual who has made a noteworthy contribution to preventing and treating vision impairment. 

Share:          
CWWeekly

February 21

Survey: Sponsors, CROs making changes to their business models to demonstrate value to payers

Cegedim ranks top pharma companies on their use of, and success with, social media

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

February

Anticipating the rise of virtual drug development
With the rising cost of drug development and a continued shortage of new products entering the marketplace, the virtual pharma model is expected to become more prevalent going forward, particularly as pharma companies have...

Closing investigative site operations a complex process
In light of the shrinking investigative site landscape, CenterWatch has conducted in-depth case studies of sites closing their operations. Site personnel offer insights into...

Eye On Shire
Shire is a rapidly growing, global specialty biopharmaceutical company, directly marketing its products in over 50 countries...

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs